An investigational antibody demonstrated an ability to preserve vision in people with geographic atrophy from dry age-related ...

Alkeus Pharmaceuticals’ study results from Gildeuretinol shows significant trend in slowing geographic atrophy: Cambridge, Massachusetts Friday, October 25, 2024, 10:00 Hrs [IST ...

There are various factors that may potentially increase the risk of developing AMD, such as advancing age (over 50); having a ...

Age-related macular degeneration (AMD) is one of the leading causes of vision ... researchers are still looking for more accessible and affordable treatments for all forms of AMD. Since AMD is closely ...

A new statistical models shed light on why some patients can extend the dosing interval with Eylea (aflibercept) from 8 weeks ...

Carrots are believed to support eye health because of their carotenoid content. Learn what’s true and best: raw, cooked, or ...

While adverse events (AEs) were reported for 97% of trial participants, such cases were predominantly mild to moderate.

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive topline one-year results from ...

The ELEVATUM study showed clinically meaningful improvement in vision and reduction in retinal fluid in people with diabetic ...

Your eyesight is precious, and you should do what you can to preserve it. Here are the best and worst foods for macular ...

SOL-1 is now expected to be enrolled and fully randomized by year-end 2024. Topline clinical data from SOL-1 are now expected in Q4 2025. BEDFORD, Mass., Oct. 15, 2024 (GLOBE NEWS ...

The global pharmaceutical industry will generate more than $1.2 trillion in sales in 2025, according to Statista. A large portion of that figure is from the oncology segment, which is expected ...